COVID-19

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

UPDATED May 4, 2023: FAQs for Clinical Research During the Coronavirus Pandemic Retired

Researchers from Clinical Futures, a CHOP Research Institute Center of Emphasis, are studying best practices for telemedicine in pediatric primary care.

New study findings can inform optimal COVID-19 vaccination strategy during pregnancy.

Learn how computational science experts help advance our data-driven research at CHOP.

This week’s news roundup features discoveries related to COVID-19’s effect on adolescents, autism screening, telemedicine, and more.

This week’s In the News highlights young cancer survivors, COVID-19, awards for two CHOP oncologists, and a tool to evaluate cancer mutations.

CHOP engineers are researching how to optimize point-of-care manufacturing within hospitals to save lives while staying safe and compliant.

PolicyLab’s 2022 forum, “Bridging New Partnerships, Creating Change,” will take place May 9-10 at the Kimmel Center.

This week’s news roundup features CHOP’s Forbes’ ranking, a cancer research editorial by Madeline Bell, mask mandates, and mental disorders.